Page last updated: 2024-10-30

letrozole and Leiomyomatosis

letrozole has been researched along with Leiomyomatosis in 2 studies

Leiomyomatosis: The state of having multiple leiomyomas throughout the body. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" The long-term use of aromatase inhibitor therapy is thought to be effective and safe for patients with recurrence after BSO."1.46Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata. ( Ando, H; Kusunoki, S; Matsuoka, S; Ogishima, D; Ota, T; Sugimori, Y, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H1
Kusunoki, S1
Ota, T1
Sugimori, Y1
Matsuoka, S1
Ogishima, D1
Biri, A1
Korucuoglu, U1
Zumrutbas, N1
Tiras, B1
Guner, H1

Other Studies

2 other studies available for letrozole and Leiomyomatosis

ArticleYear
Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata.
    The journal of obstetrics and gynaecology research, 2017, Volume: 43, Issue:9

    Topics: Adult; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Neoplasm Recurrence, Local;

2017
Intravenous leiomyomatosis treated with aromatase inhibitor therapy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 101, Issue:3

    Topics: Adult; Angiography; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Nitriles; Treat

2008